Focal and diffuse beta cell changes in persistent hyperinsulinemic hypoglycemia of infancy

Endocrine Pathology

Volumn 10, Issue 4, 1999, Pages 299-304

  Klöppel, Günter ^a   Reinecke Lüthge, Axel ^b   Koschoreck, Frank ^b  

^a UNIVERSITY OF KIEL   (Germany)

^b NONE

Author keywords

Endocrine pancreas; Molecular changes; Persistent hyperinsulinemic hypoglycemia in infancy

Indexed keywords

ARTICLE; DISEASE CLASSIFICATION; GENE MUTATION; HUMAN; HYPERINSULINEMIA; HYPOGLYCEMIA; IMMUNOCYTOCHEMISTRY; INFANT; INFANT DISEASE; PANCREAS ISLET BETA CELL; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0033496629     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02739772     Document Type: Article

References (31)

1. 1. Goossens A, Heitz PU, Klöppel G. Pancreatic endocrine cells and their non-neoplastic proliferations. In: Dayal Y, ed. Endocrine pathology of the gut and pancreas. Boca Raton: CRC Press 69-104, 1991.
2. 2. Meissner T, Beinbrech B, Mayatepek E. Congenital hyperinsulinism: molecular basis of a heterogeneous disease. Hum Mutat 13:351-361, 1999.
3. 3. Baker L, Stanley CA. Hyperinsulinism in infancy: A pathophysiologic approach to diagnosis and treatment. In: Chiumelo G, Laron Z, ed. Recent progress in pediatric endocrinology. New York: Academic Press, 89-100, 1977.
4. 4. Aynsley-Green A, Polak JM, Bloom SR, Gough MH, Keeling J, Ashcroft SJ, Turner RC, Baum JD. Nesidioblastosis of the pancreas: definition of the syndrome and the management of the severe neonatal hyper-insulinemic hypoglycemia. Arch Dis Child 56:496-508, 1981.
5. 5. Heitz PU, Klöppel G, Häcki WH, Polak JM, Pearse AGE. Nesidioblastosis: the pathologic basis of persistent hyperinsulinemic hypoglycemia in infants. Morphologic and quantitative analysis of seven cases based on specific immunostaining and electron microscopy. Diabetes 26:632-642, 1977.
6. 6. Goossens A, Gepts W, Saudubray JM, Bonnefont JP, Nihoul-Fekete C, Heitz PU, Klöppel G. Diffuse and focal nesidioblastosis: A clinicopathological study of 24 patients with persistent neonatal hyperinsulinemic hypoglycemia. Am J Surg Pathol 13:766-775, 1989.
7. 7. Rahier J. Relevance of endocrine pancreas nesidioblastosis to hyperinsulinemic hypoglycemia. Diabetes Care 12:164-166, 1989.
8. 8. Laidlaw GF. Nesidioblastoma, the islet tumor of the pancreas. Am J Pathol 14:125-134, 1938.
9. 9. Hirsch HJ, Loo S, Evans N, Crigler JF, Filler RM, Gabbay KH. Hypoglycemia of infancy and nesidioblastosis. Studies with somatostatin. N Engl J Med 296:1323-1326, 1977.
10. 10. Thornton PS, Alter CA, Katz LE, Baker L, Stanley CA. Short-and long-term use of octreotide in the treatment of congenital hyperinsulinism. J Pediatr 123:637-643, 1993.
11. 11. Shilyansky J, Fisher S, Cutz E, Perlman K, Filler RM. Is 95% pancreatectomy the procedure of choice for treatment of persistent hyperinsulinemic hypoglycemia of the neonate? J Pediatr Surg 32:342-346, 1997.
12. 12. de Lonlay-Debeney P, Poggi-Travert F, Fournet JC, Sempoux C, Vici CD, Brunelle F, Touari G, Rahier J, Junien C, Nihoul-Fékété C, Robert JJ, Saudubray JM. Clinical features of 52 neonates with hyperinsulinism. N Engl J Med 340:1169-1175, 1999.
13. 13. Leibowitz G, Glaser B, Higazi AA, Salameh M, Cerasi E, Landau H. Hyperinsulinemic hypoglycemia of infancy (nesidioblastosis) in clinical remission: high incidence of diabetes mellitus and persistent beta-cell dysfunction at long-term follow-up. J Clin Endocrinol Metab 80:386-392, 1995.
14. 14. Jaffe R, Hashida Y, Yunis EJ. Pancreatic pathology in hyperinsulinemic hypoglycemia of infancy. Lab Invest 42:356-365, 1980.
15. 15. Klöppel G, Heitz PU. Nesidioblastosis: A clinical entity with heterogeneous lesions of the pancreas. In: Falkmer S, Hakanson R, Sundler F, ed. Evolution and tumour pathology of the neuroendocrine system. Amsterdam New York Oxford: Elsevier, 349-370, 1984.
16. 16. Rahier J, Fält K, Müntefering H, Becker K, Gepts W, Falkmer S. The basic structural lesion of persistent neonatal hypoglycaemia with hyperinsulinism: deficiency of islet somatostatin cells or hyperactivity of the insulin cells? Diabetologia 26:282-289, 1984.
17. 17. Klöppel G, Altenähr E, Menke B. The ultra-structure of focal islet cell adenomatosis in the newborn with hypoglycemia and hyperinsulinism. Virchows Arch [A] Pathol Anat 366:223-236, 1975.
18. 18. Bordi C, Ravazzola M, Pollak A, Lubec G, Orci L. Neonatal islet cell adenoma: a distinct type of islet cell tumor? Diabetes Care 5:122-125, 1982.
19. 19. Rahier J, Sempoux C, Fournet JC, Poggi F, Brunelle F, Nihoul-Fekete C, Saudubray JM, Jaubert F. Partial or near-total pancreatectomy for persistent neonatal hyperinsulinaemic hypoglycaemia: the pathologist's role. Histopathology 32:15-19, 1998.
20. 20. Sempoux C, Guiot Y, Dubois D, Nollevaux MC, Saudubray JM, Nihoul-Fekete C, Rahier J. Pancreatic B-cell proliferation in persistent hyperinsulinemic hypoglycemia of infancy: an immunohistochemical study of 18 cases. Mod Pathol 11:444-449, 1998.
21. 21. Aguilar-Bryan L, Bryan J. ATP-sensitive potassium channels, sulfonylurea receptors, and persistent hyperinsulinemic hypoglycemia of infancy. Diabetes Rev 4:336-346, 1996.
22. 22. Nestorowicz A, Glaser B, Wilson BA, Shyng SL, Nichols CG, Stanley CA, Thornton PS, Permutt MA. Genetic heterogeneity in familial hyperinsulinism. Hum Mol Genet 7:1119-1128, 1998.
23. 23. Glaser B, Chiu KC, Anker R, Nestorowicz A, Landau H, Ben-Bassat H, Shlomai Z, Kaiser N, Thornton PS, Stanley CA, Spielman RS, Gogolin-Ewens K, Cerasi E, Baker L, Rice J, Donis-Keller H, Permutt MA. Familial hyperinsulinism maps to chromosome 11p14-15.1, 30 cM centromeric to the insulin gene. Nat Genet 7:185-188, 1994.
24. 24. Thomas PM, Cote GJ, Wohlik N, Haddad B, Mathew PM, Rabl W, Aguilar-Bryan L, Gagel RF, Bryan J. Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. Science 268:426-429, 1995.
25. 25. Dunne MJ, Kane C, Shepherd RM, Sanchez JA, James RF, Johnson PR, Aynsley-Green A, Lu S, Clement JP, Lindley KJ, Seino S, Aguilar-Bryan L. Familial persistent hyperinsulinemic hypoglycemia of infancy and mutations in the sulfonylurea receptor. N Engl J Med 336:703-706, 1997.
26. 26. Nestorowicz A, Inagaki N, Gonoi T, Schoor KP, Wilson BA, Glaser B, Landau H, Stanley CA, Thornton PS, Seino S, Permutt MA. A non-sense mutation in the inward rectifier potas-sium channel gene, Kir6.2, is associated with familial hyperinsulinism. Diabetes 46:1743-1748, 1997.
27. 27. Stanley CA, Lieu YK, Hsu BY, Burlina AB, Greenberg CR, Hopwood NJ, Perlman K, Rich BH, Zammarchi E, Poncz M. Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene. N Engl J Med 338:1352-1357, 1998.
28. 28. Glaser B, Kesavan P, Heyman M, Davis E, Cuesta A, Buchs A, Stanley CA, Thornton PS, Permutt MA, Matschinsky FM, Herold KC. Familial hyperinsulinism caused by an activating glucokinase mutation. N Engl J Med 338:226-230, 1998.
29. 29. Albers N, Löhr M, Bogner U, Loy V, Klöppel G. Nesidioblastosis of the pancreas in an adult with persistent hyperinsulinemic hypoglycemia. Am J Clin Pathol 91:336-340, 1989.
30. 30. Rinker RD, Friday K, Aydin F, Jaffe BM, Lambiase L. Adult nesidioblastosis: a case report and review of the literature. Dig Dis Sci 43:1784-1790, 1998.
31. 31. de Lonlay P, Fournet JC, Rahier J, Gross-Morand MS, Poggi-Travert F, Foussier V, Bonnefont JP, Brusset MC, Brunelle F, Robert JJ, Nihoul-Fékété C, Saudubray JM, Junien C. Somatic deletion of the imprinted 11p15 region in sporadic persistent hyperinsulinemic hypoglycemia of infancy is specific of focal adenomatous hyperplasia and endorses partial pancreatectomy. J Clin Invest 100:802-807, 1997.